soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Reduces Events in People with Type 2 Diabetes with Atherosclerotic NEJM Editorial Fellow Harleen Marwah,
Pay in 4 interest-free payments of $5.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25













.png)












